AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 280, Issue 5 43-5, 2001, Pages

  Musi, Nicolas ^a   Hayashi, Tatsuya ^a   Fujii, Nobuharu ^a   Hirshman, Michael F ^a   Witters, Lee A ^b   Goodyear, Laurie J ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

Adenosine 5 monophosphate activated protein kinase; Contraction

Indexed keywords

3 METHYLGLUCOSE; 8 BROMO CYCLIC AMP; ADENYLATE KINASE; TUBERCIDIN; VIDARABINE;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVATION; ENZYME SUBUNIT; GLUCOSE TRANSPORT; MALE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; TREADMILL EXERCISE;

EID: 0034999425     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.280.5.e677     Document Type: Article

References (44)

1. Abbud W, Habinowski S, Zhang JZ, Kendrew J, Elkairi FS, Kemp BE, Witters LA, and Ismail-Beigi F. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of GLUT1-mediated glucose transport. Arch Biochem Biophys 380: 347-352, 2000.
2. Baldwin KM, Campbell PJ, and Cooke DA. Glycogen, lactate, and alanine changes in muscle fiber types during graded exercise. J Appl Physiol 43: 288-291, 1977.
3. Bergeron R, Russell RRIII, Young LH, Ren JM, Marcucci M, Lee A, and Shulman GI. Effect of AMPK activation on muscle glucose metabolism in conscious rats. Am J Physiol Endocrinol Metab 276: E938-E944, 1999.
4. Bogardus C, Ravussin E, Robbins DC, Wolfe RR, Horton ES, and Sims EAH. Effects of physical training and diet therapy on carbohydrate metabolism in patients with glucose intolerance and non-insulin-dependent diabetes mellitus. Diabetes 33: 311-318, 1984.
5. Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ, and Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 279: E1202-E1206, 2000.
6. Davies SP, Carling D, and Hardie DG. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay. Eur J Biochem 186: 123-128, 1989.
7. Dean DJ, Kaushik V, Lin T, Kurowski T, and Ruderman NB. Stimulation of muscle glucose transport by 5-aminoimidazole-4-carboxamide 1-β-D-ribofuranoside (AICAR) varies with fiber type (Abstract). Diabetes 49, Suppl 1: A193, 2000.
8. Derave W, Ai H, Ihlemann J, Witters LA, Kristiansen S, Richter EA, and Ploug T. Dissociation of AMP-activated protein kinase activation and glucose transport in contracting slow-twitch muscle. Diabetes 49: 1281-1287, 2000.
9. Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, and Goodyear LJ. Exercise induces isoform-specific increase in 5′ AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 273: 1150-1155, 2000.
10. Goodyear LJ, Giorgino F, Balon TW, Condorelli G, and Smith RJ. Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab 268: E987-E995, 1995.
11. Goodyear LJ, Hirshman MF, King PA, Thompson CM, Horton ED, and Horton ES. Skeletal muscle plasma membrane glucose transport and glucose transporters after exercise. J Appl Physiol 68: 193-198, 1990.
12. Goodyear LJ and Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49: 235-261, 1998.
13. Hardie DG and Carling D. The AMP-activated protein kinase - fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997.
14. Hardie DG, Carling D, and Carlson M. The AMP-activated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
15. Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, and Goodyear LJ. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49: 527-531, 2000.
16. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, and Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 47: 1369-1373, 1998.
17. Hayashi T, Wojtaszewski JF, and Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 273: E1039-E1051, 1997.
18. Henderson JF, Paterson AR, Caldwell IC, Paul B, Chan MC, and Lau KF. Inhibitors of nucleoside and nucleotide metabolism. Cancer Chemother Rep 3: 71-85, 1972.
19. Henin N, Vincent MF, and Van den Berghe G. Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim Biophys Acta 1290: 197-203, 1996.
20. Hermensen L, Pruett EDR, Osnes JB, and Giere FA. Blood glucose and plasma insulin in response to maximal exercise and glucose infusion. J Appl Physiol 29: 13-16, 1970.
21. Holloszy JO and Hansen PA. Regulation of glucose transport into skeletal muscle. Rev Physiol Biochem Pharmacol 128: 99-193, 1996.
22. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, and Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 24: 22-25, 1999.
23. Kennedy JW, Hirshman MF, Gervino EV, Ocel JV, Forse RA, Hoenig SJ, Aronson D, Goodyear LJ, and Horton ES. Acute exercise induces GLUT-4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes 48: 1192-1197, 1999.
24. King PA, Betts JJ, Horton ED, and Horton ES. Exercise, unlike insulin, promotes glucose transporter translocation in obese Zucker rat muscle. Am J Physiol Regulatory Integrative Comp Physiol 265: R447-R452, 1993.
25. King PA, Horton ED, Hirshman MF, and Horton ES. Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest 90: 1568-1575, 1992.
26. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, and Winder WW. 5′ AMP-activated protein kinase activation causes GLUT-4 translocation in skeletal muscle. Diabetes 48: 1667-1671, 1999.
27. Lee AD, Hansen PA, and Holloszy JO. Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 361: 51-54, 1995.
28. Lund S, Holman GD, Schmitz O, and Pedersen O. Contraction stimulates translocation of glucose transporter GLUT-4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci USA 92: 5817-5821, 1995.
29. Massillon D, Stalmans W, van de Werve G, and Bollen M. Identification of the glycogenic compound 5-iodotubercidin as a general protein kinase inhibitor. Biochem J 299: 123-128, 1994.
30. Merrill GF, Kurth EJ, Hardie DG, and Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 273: E1107-E1112, 1997.
31. Parkinson FE and Geiger JD. Effects of iodotubercidin on adenosine kinase activity and nucleoside transport in DDT1 MF-2 smooth muscle cells. J Pharmacol Exp Ther 277: 1397-1401, 1996.
32. Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, and Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 17: 1688-1699, 1998.
33. Pruett EDR and Oseid S. Effect of exercise on glucose and insulin response to glucose infusion. Scand J Clin Lab Invest 26: 277-285, 1970.
34. Rasmussen BB, Hancock CR, and Winder WW. Postexercise recovery of skeletal muscle malonyl-CoA, acetyl-CoA carboxylase, and AMP-activated protein kinase. J Appl Physiol 85: 1629-1634, 1998.
35. Rasmussen BB and Winder WW. Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase. J Appl Physiol 83: 1104-1109, 1997.
36. Russell RR III, Bergeron R, Shulman GI, and Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol Heart Circ Physiol 277: H643-H649, 1999.
37. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, and Hardie DG. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform. Biochem J 334: 177-187, 1998.
38. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, and Kemp BE. Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271: 611-614, 1996.
39. Vavvas D, Apazidis A, Saha AK, Gamble J, Patel A, Kemp BE, Witters LA, and Ruderman NB. Contraction-induced changes in acetyl-CoA carboxylase and 5′-AMP-activated kinase in skeletal muscle. J Biol Chem 272: 13255-13261, 1997.
40. Winder WW and Hardie DG. Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am J Physiol Endocrinol Metab 270: E299-E304, 1996.
41. Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, and Kiens B. Isoform-specific and exercise intensity-dependent activation of 5′-AMP-activated protein kinase in human skeletal muscle. J Physiol (Lond) 528: 221-226, 2000.
42. Woods A, Salt I, Scott J, Hardie DG, and Carling D. The α1 and α2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 397: 347-351, 1996.
43. Yeh JI, Gulve EA, Rameh L, and Birnbaum MJ. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin-and contraction-activated hexose transport. J Biol Chem 270: 2107-2111, 1995.
44. Zierath JR, He L, Guma A, Odegoard Wahlstrom E, Klip A, and Wallberg-Henriksson H. Insulin action on glucose transport and plasma membrane GLUT-4 content in skeletal muscle from patients with NIDDM. Diabetologia 39: 1180-1189, 1996.